Punitha Rathnam, MD
Psychiatry · Goldsboro, NCNPI 1558564005
Payments from drug & device makers
Across 563 payments — averaging $1048.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$289K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$175K
- Alkermes, Inc.$75K
- Vanda Pharmaceuticals Inc.$46K
- Otsuka America Pharmaceutical, Inc.$1K
- Brainsway USA Inc$705
- plus $3K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 198 | $289,404 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 14 | $174,716 |
| Alkermes, Inc. | 68 | $75,023 |
| Vanda Pharmaceuticals Inc. | 39 | $46,375 |
| Otsuka America Pharmaceutical, Inc. | 68 | $1,112 |
| Brainsway USA Inc | 1 | $705 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $603 |
| Teva Pharmaceuticals USA, Inc. | 32 | $561 |
| Johnson & Johnson | 26 | $407 |
| Neurocrine Biosciences, Inc. | 16 | $269 |
| Supernus Pharmaceuticals, Inc. | 16 | $258 |
| Lundbeck LLC | 10 | $178 |
| Corium, LLC | 7 | $105 |
| Tris Pharma Inc | 5 | $88 |
| Ironshore Pharmaceuticals Inc. | 5 | $83 |
| E.r. Squibb & Sons, L.L.C. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $62 |
| Sunovion Pharmaceuticals Inc. | 2 | $46 |
| Shire North American Group Inc | 2 | $30 |
| Eisai Inc. | 2 | $28 |
| Neos Therapeutics, LP | 2 | $27 |
| Almatica Pharma LLC | 1 | $18 |
| Luye Pharma (USA) Ltd. | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
How this compares
$590,257 in reported general payments places this provider in the 95th percentile of 1,108 psychiatry providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Goldsboro
- Meredith GodwinGoldsboro$21K
- Craig ChepkeHuntersville$4.1M
- James BarkerHickory$4.1M
- Mark ReynoldsDurham$3.2M
- Oleg TcheremissineCharlotte$2M
- Richard WeislerRaleigh$1.2M
- Dan BlazerDurham$1M
- Samantha Meltzer-BrodyChapel Hill$909K
- Andrew KrystalDurham$754K
- Brian FarahWinston Salem$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.